4 Front Ventures Corp. FFNTF
We take great care to ensure that the data presented and summarized in this overview for 4Front Ventures Corp. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in FFNTF
Top Purchases
Top Sells
About FFNTF
4Front Ventures Corp. owns and manages licensed cannabis facilities in state-licensed markets in the United States. The company operates in two segments, THC Cannabis and Cannabidiol (CBD) Wellness. It produces, cultivates, sells, and distributes cannabis and CBD. As of December 31, 2021, it operated six dispensaries in Massachusetts, Illinois, and Michigan primarily under the MISSION brand name. In addition, the company sells equipment, supplies, and intellectual property to cannabis producers; imports and sale equipment and supplies; leases real estate properties to cannabis producers; offers consulting services; and operates cannabis dispensaries. 4Front Ventures Corp. was founded in 2011 and is based in Phoenix, Arizona.
Insider Transactions at FFNTF
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 02
2024
|
Leonid Gontmakher |
BUY
Grant, award, or other acquisition
|
Direct |
1,342,725
+1.51%
|
-
|
|
May 02
2024
|
Karl Chowscano |
BUY
Grant, award, or other acquisition
|
Indirect |
3,333,333
+9.63%
|
-
|
|
May 02
2024
|
Peter Kampian Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
877,321
+50.0%
|
-
|
|
May 02
2024
|
Kristopher Krane |
BUY
Grant, award, or other acquisition
|
Direct |
411,270
+3.66%
|
-
|
|
May 02
2024
|
Andrew Thut Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,000,000
+28.05%
|
-
|
|
May 02
2024
|
Roman Tkachenko |
BUY
Grant, award, or other acquisition
|
Direct |
342,725
+2.3%
|
-
|
|
May 02
2024
|
David Ryan Daily |
BUY
Grant, award, or other acquisition
|
Direct |
411,270
+48.7%
|
-
|
|
Sep 07
2023
|
Leonid Gontmakher |
BUY
Open market or private purchase
|
Direct |
20,000
+0.05%
|
$0
$0.24 P/Share
|
|
Sep 06
2023
|
Leonid Gontmakher |
BUY
Open market or private purchase
|
Direct |
75,000
+0.18%
|
$0
$0.22 P/Share
|
|
Aug 29
2023
|
Leonid Gontmakher |
BUY
Open market or private purchase
|
Direct |
14,500
+0.05%
|
$0
$0.12 P/Share
|
|
Aug 17
2023
|
Leonid Gontmakher |
BUY
Grant, award, or other acquisition
|
Direct |
9,300,250
+18.35%
|
-
|
|
Aug 04
2023
|
Andrew Thut Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,405,818
+14.59%
|
-
|
|
Aug 04
2023
|
Karl Chowscano |
BUY
Grant, award, or other acquisition
|
Indirect |
2,806,788
+13.54%
|
-
|
|
Nov 16
2022
|
Leonid Gontmakher |
BUY
Grant, award, or other acquisition
|
Direct |
1,750,604
+5.18%
|
-
|
|
Jun 29
2022
|
Chetan Gulati Director |
SELL
Other acquisition or disposition
|
Indirect |
2,068,082
-8.69%
|
-
|
|
Jun 17
2022
|
Chetan Gulati Director |
SELL
Open market or private sale
|
Indirect |
7,500
-0.03%
|
$0
$0.63 P/Share
|
|
Jun 15
2022
|
Chetan Gulati Director |
SELL
Open market or private sale
|
Indirect |
500
-0.0%
|
$0
$0.66 P/Share
|
|
Jun 14
2022
|
Chetan Gulati Director |
SELL
Open market or private sale
|
Indirect |
1,000
-0.0%
|
$0
$0.66 P/Share
|
|
Jun 13
2022
|
Chetan Gulati Director |
SELL
Open market or private sale
|
Indirect |
168,000
-0.7%
|
$0
$0.67 P/Share
|
|
Jun 10
2022
|
Chetan Gulati Director |
SELL
Open market or private sale
|
Indirect |
300,000
-1.24%
|
$0
$0.68 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 30.2M shares |
|---|---|
| Open market or private purchase | 110K shares |